Farhat Ghaznawi

979 total citations · 1 hit paper
10 papers, 437 citations indexed

About

Farhat Ghaznawi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Farhat Ghaznawi has authored 10 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Farhat Ghaznawi's work include Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Farhat Ghaznawi is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Farhat Ghaznawi collaborates with scholars based in United States, Switzerland and Spain. Farhat Ghaznawi's co-authors include Mathilde Kaper, Yen‐Shen Lu, Mario Campone, Michelle C. Miller, Dejan Juric, Hope S. Rugo, Pierfranco Conté, Toshinari Yamashita, Fabrice André and Sibylle Loibl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Farhat Ghaznawi

9 papers receiving 427 citations

Hit Papers

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone re... 2020 2026 2022 2024 2020 100 200 300

Peers

Farhat Ghaznawi
Comparison fields: 5 of 47
  • Pulmonary and Respiratory Medicine 245
  • Oncology 224
  • Molecular Biology 173
  • Cancer Research 170
  • Genetics 83
Replace Eirini Thanopoulou with:
Eirini Thanopoulou United Kingdom
Douglas Robinson United States
Prateek Mendiratta United States
Gillianne Lai Singapore
Anna Wurtz United States
Sarah Abou Alaiwi United States
Magnus Zethoven Australia
Amy Tilley United States
HS Rugo United States
Yoon Ming Chin Japan
Eirini Thanopoulou United Kingdom View profile →
Citations per field, relative to Farhat Ghaznawi
Farhat Ghaznawi · 1×
Citations per year, relative to Farhat Ghaznawi
Farhat Ghaznawi · 1×

Countries citing papers authored by Farhat Ghaznawi

Since Specialization
Citations

This map shows the geographic impact of Farhat Ghaznawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhat Ghaznawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhat Ghaznawi more than expected).

Fields of papers citing papers by Farhat Ghaznawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhat Ghaznawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhat Ghaznawi. The network helps show where Farhat Ghaznawi may publish in the future.

Co-authorship network of co-authors of Farhat Ghaznawi

This figure shows the co-authorship network connecting the top 25 collaborators of Farhat Ghaznawi. A scholar is included among the top collaborators of Farhat Ghaznawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhat Ghaznawi. Farhat Ghaznawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Work Indexed citations
1 5
2 0
3 4
4 4
5 3
6 16
7 9
8
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 breakdown →
371
9 24
10 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026